Search company, investor...

Executives

4

Board of Directors

1

Atriva Therapeutics Management Team

4 Team Members

Atriva Therapeutics has 4 executives. Atriva Therapeutics's current Chief Executive Officer, President is Rainer Lichtenberger.

Name

Work History

Title

Status

Rainer Lichtenberger

Chief Executive Officer, President

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Rainer Lichtenberger

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer, President

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Atriva Therapeutics Board of Director

1 Board of directors

Atriva Therapeutics has 1 board of directors, including Frank Hensel.

Name

Firm

Work History

Other Seats

Frank Hensel

Dr. Frank Hensel is Principal at the High-Tech Gründerfonds (HTGF) and an expert in the early stage financing of life science start-ups. Frank joined the HTGF in 2015 and successfully managed the investments in several early stage biotech companies. He is an active Board member and holds Board Observer positions in several life science companies developing novel (anti-cancer) therapeutics and medical devices. In 2001, Frank became CEO and Co-Founder of OncoMab GmbH, a spin-off of the University of Würzburg’s Institute of Pathology, where he was involved in several milestone achievements regarding product and business development as well as the company’s transition to the Australian stock exchange. He studied Biophysics at University Osnabrück and holds a PhD in the area of tumor-reactive antibodies from the Ludwig Maximilians University of Würzburg.

Atriva Therapeutics

Name

Frank Hensel

Firm

Work History

Dr. Frank Hensel is Principal at the High-Tech Gründerfonds (HTGF) and an expert in the early stage financing of life science start-ups. Frank joined the HTGF in 2015 and successfully managed the investments in several early stage biotech companies. He is an active Board member and holds Board Observer positions in several life science companies developing novel (anti-cancer) therapeutics and medical devices. In 2001, Frank became CEO and Co-Founder of OncoMab GmbH, a spin-off of the University of Würzburg’s Institute of Pathology, where he was involved in several milestone achievements regarding product and business development as well as the company’s transition to the Australian stock exchange. He studied Biophysics at University Osnabrück and holds a PhD in the area of tumor-reactive antibodies from the Ludwig Maximilians University of Würzburg.

Other Seats

Atriva Therapeutics

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.